One-Stop Service to ADCs and Payload-Linkers with a Strong US Presencex

2:45 pm - Wednesday 29th July 2026

  • Site integration to promote rapid development and delivery of ADCs and other bioconjugates with compressed timelines
  • Track record in new modalities such as bispecific mAbs and dual payload ADCs
  • New Jersey site (J-Star Research) serves as the center of synthetic innovation in HPAPI research

Speakers:

Senior Director
Porton Pharma